JONATHAN JARMAN: Open Payments
NPI 1457047995 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $25 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $200 |
| ABBVIE INC. | 2 | $178 |
| Incyte Corporation | 2 | $46 |
| Galderma Laboratories, L.P. | 1 | $41 |
| GENZYME CORPORATION | 1 | $39 |
| Janssen Biotech, Inc. | 1 | $23 |
| Botanix SB Inc | 1 | $18 |
Products named: ILUMYA, RINVOQ, OPZELURA, NEMLUVIO, DUPIXENT, TREMFYA, SOFDRA.
Industry payments across NY — which companies pay providers there.
